Mesoblast Limited American Depositary Shares (MESO) Stock Price

MESOStock

$13.28−31.62%52W

Market Cap$1.72B

P/E—

PEG Ratio—

Div yield—

Beta1.03

MESO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.46%

Price vs S&P 500 (4W)-5.25%

VGM Score60.30

Book Value / Share (Quarterly)$0.44

P/TBV (Annual)12.88x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)152.15%

Cash Flow / Share (Quarterly)$-0.03

Price vs S&P 500 (YTD)-37.40%

Gross Margin (TTM)86.14%

Net Profit Margin (TTM)-47.82%

EPS (TTM)$-0.04

10-Day Avg Trading Volume4.28M

EPS Excl Extra (TTM)$-0.04

Revenue Growth (5Y)74.39%

EPS (Annual)$-0.04

ROI (Annual)-8.26%

Gross Margin (Annual)86.14%

Net Profit Margin (5Y Avg)-823.61%

Cash / Share (Quarterly)$0.04

Revenue Growth QoQ (YoY)390.73%

ROA (Last FY)-7.44%

Revenue Growth TTM (YoY)599.21%

EBITD / Share (TTM)$-0.03

ROE (5Y Avg)-16.05%

Operating Margin (TTM)-33.28%

Cash Flow / Share (Annual)$-0.03

P/B Ratio3.08x

P/B Ratio (Quarterly)3.09x

Net Income / Employee (Annual)$-709,900

EV / Revenue (TTM)15.24x

Net Interest Coverage (TTM)-2.82x

ROA (TTM)-7.39%

EPS Incl Extra (Annual)$-0.04

Current Ratio (Annual)2.43x

Quick Ratio (Quarterly)1.98x

3-Month Avg Trading Volume3.14M

52-Week Price Return-31.62%

Revenue / Employee (TTM)$1,484,600

Tangible BV / Share (Quarterly)$0.11

P/S Ratio (Annual)14.57x

Asset Turnover (Annual)0.16x

52-Week High$3.31

Operating Margin (5Y Avg)-651.74%

EPS Excl Extra (Annual)$-0.04

CapEx CAGR (5Y)-12.75%

Tangible BV CAGR (5Y)0.17%

26-Week Price Return-11.56%

Quick Ratio (Annual)1.98x

13-Week Price Return-18.11%

Total Debt / Equity (Annual)0.22x

Current Ratio (Quarterly)2.43x

Enterprise Value$1.83B

Revenue / Share Growth (5Y)51.34%

Asset Turnover (TTM)0.15x

Book Value / Share Growth (5Y)-12.42%

Revenue / Employee (Annual)$1,484,600

Pretax Margin (Annual)-47.31%

Cash / Share (Annual)$0.04

3-Month Return Std Dev48.90%

Gross Margin (5Y Avg)-96.17%

Net Income / Employee (TTM)$-709,900

ROE (Last FY)-10.12%

Net Interest Coverage (Annual)-2.82x

EPS Basic Excl Extra (Annual)$-0.04

Receivables Turnover (TTM)3.39x

Total Debt / Equity (Quarterly)0.22x

EPS Incl Extra (TTM)$-0.04

Receivables Turnover (Annual)3.39x

ROI (TTM)-8.18%

P/S Ratio (TTM)14.57x

Pretax Margin (5Y Avg)-824.80%

Revenue / Share (Annual)$0.09

Tangible BV / Share (Annual)$0.11

Forward P/E93.93x

Price vs S&P 500 (52W)-47.15%

Year-to-Date Return-26.84%

5-Day Price Return-3.40%

EPS Normalized (Annual)$-0.04

ROA (5Y Avg)-11.93%

Net Profit Margin (Annual)-47.82%

Month-to-Date Return-5.69%

Cash Flow / Share (TTM)$-0.16

EBITD / Share (Annual)$-0.03

Operating Margin (Annual)-33.53%

LT Debt / Equity (Annual)0.19x

ROI (5Y Avg)-13.08%

LT Debt / Equity (Quarterly)0.19x

EPS Basic Excl Extra (TTM)$-0.04

P/TBV (Quarterly)12.88x

P/B Ratio (Annual)3.09x

Inventory Turnover (TTM)0.66x

Pretax Margin (TTM)-47.31%

Book Value / Share (Annual)$0.44

Price vs S&P 500 (13W)-20.79%

Beta1.03x

P/FCF (Annual)16.50x

Revenue / Share (TTM)$0.09

ROE (TTM)-10.06%

52-Week Low$1.74

vGradeD

gGradeA

mGradeC

vgmGradeB

MESO Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.10

Industry Peers — Biological Products(186)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
MESOMesoblast Limited American Depositary Shares	D	A	C	14.6x	599.2%	86.1%	—	$13.28
AMGNAmgen Inc	D	C	A	6.1x	9.1%	74.3%	2.9%	$432.49
GILDGilead Sciences Inc	C	B	A	6.4x	5.5%	79.6%	133.6%	$156.19
MRNAModerna, Inc. Common Stock	F	C	A	39.1x	-27.6%	36.4%	—	$218.01
ARGXargenx SE American Depositary Shares	D	A	B	6.6x	165.2%	89.8%	—	$819.14
RVMDRevolution Medicines, Inc. Common Stock	F	—	B	3296.2x	—	—	—	$177.96
BIIBBiogen Inc. Common Stock	C	D	A	3.4x	0.3%	74.0%	-18.8%	$232.65
BNTXBioNTech SE American Depositary Share	C	C	C	7.6x	-11.8%	79.2%	—	$87.71
EXELExelixis Inc	C	B	A	6.3x	9.2%	96.5%	31.1%	$62.23
HALOHalozyme Therapeutics, Inc.	D	B	A	8.3x	41.1%	82.4%	22.9%	$121.84
NBIXNeurocrine Biosciences Inc	C	B	B	4.1x	34.4%	98.0%	2.3%	$135.71
TECHBio-Techne Corp.	D	C	B	9.4x	-0.4%	66.2%	6.0%	$72.57
RGENRepligen Corp	F	C	A	14.2x	16.5%	53.8%	-4.9%	$175.42
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	—	—	—	—	$135.07
PCVXVaxcyte, Inc. Common Stock	—	—	B	—	—	—	—	$63.62
IBRXImmunityBio, Inc. Common Stock	F	A	A	58.7x	192.9%	99.3%	—	$9.18
QGENQIAGEN N.V.	C	C	B	4.5x	3.0%	62.5%	4.2%	$46.13
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	21.3x	22.6%	94.6%	—	$316.58
TWSTTwist Bioscience Corporation Common Stock	D	B	A	20.2x	19.2%	52.0%	—	$132.75
KYMRKymera Therapeutics, Inc. Common Stock	F	B	B	83.0x	134.8%	—	—	$104.78
IOVAIovance Biotherapeutics, Inc. Common Stock	D	B	A	19.0x	34.5%	48.4%	—	$13.62
IMVTImmunovant, Inc. Common Stock	—	—	C	—	—	—	—	$26.73
KODKodiak Sciences Inc Common Stock	—	—	A	—	—	—	—	$85.75
CGONCG Oncology, Inc. Common stock	F	A	B	851.8x	1030.3%	-85.2%	—	$59.85
SRRKScholar Rock Holding Corporation Common Stock	F	—	C	102.7x	—	—	—	$39.90
CRSPCRISPR Therapeutics AG	D	B	B	355.6x	-64.8%	—	—	$49.25
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	B	12.4x	50.1%	75.6%	—	$24.02
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	344.7x	23.9%	—	—	$16.28
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	5.5x	105.2%	93.3%	—	$68.07
DNLIDenali Therapeutics Inc. Common Stock	F	—	C	781.1x	—	—	—	$17.61
BEAMBeam Therapeutics Inc. Common Stock	D	B	C	15.5x	158.9%	—	—	$23.47
ADMAADMA Biologics, Inc.	C	C	B	4.7x	8.0%	64.7%	—	$10.68
VCELVericel Corporation	D	B	B	6.7x	22.9%	74.6%	38.9%	$40.13
BCRXBioCryst Pharmaceuticals Inc	B	A	B	2.1x	68.7%	97.8%	—	$7.79
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	33.9x	-15.1%	3.5%	—	$3.46
NVAXNovavax Inc	C	D	B	4.5x	-61.6%	79.2%	—	$11.26
ALVOAlvotech Ordinary Shares	D	D	B	3.9x	-12.1%	60.7%	—	$5.00
VIRVir Biotechnology, Inc. Common Stock	B	B	B	5.6x	1496.1%	100.0%	—	$9.96
MAZEMaze Therapeutics, Inc. Common Stock	—	A	B	—	700.0%	—	—	$27.53
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	3.5x	20.9%	98.9%	—	$29.40
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	C	—	—	—	—	$30.07
INBXInhibrx Biosciences, Inc. Common Stock	D	C	A	944.3x	550.0%	—	—	$89.83
TSHATaysha Gene Therapies, Inc. Common Stock	D	C	D	120.7x	-32.3%	—	—	$3.62
IMTXImmatics N.V. Ordinary Shares	C	C	C	21.5x	-68.0%	—	—	$6.73
REPLReplimune Group, Inc.	—	—	B	—	—	—	—	$10.86
VORVor Biopharma Inc. Common Stock	—	—	C	—	—	—	—	$18.03
MGTXMeiraGTx Holdings plc Ordinary Shares	C	A	C	2.2x	948.4%	98.0%	—	$9.28
SLBTSL Science Holding Limited Ordinary Shares	—	—	D	—	—	—	—	$1.53
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	C	—	—	—	—	$12.93
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	D	28.9x	-83.9%	—	—	$9.74
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	B	168.6x	-19.0%	—	—	$17.17

About Mesoblast Limited American Depositary Shares

Mesoblast is a commercial-stage biotechnology company developing allogeneic cellular medicines for serious inflammatory and degenerative diseases. Key programs include Ryoncil for steroid-refractory acute graft-versus-host disease and acute respiratory distress syndrome, Revascor for chronic heart failure, and a candidate for chronic low back pain. The company leverages a proprietary adult stem cell technology platform designed for off-the-shelf therapeutic applications.